IVD Devices: Histoplasma Urine Antigen LFA

MiraVista Diagnostics’ dedication to innovation and improved accessibility to high quality fungal diagnostics has created a CE marked Histoplasma Urine Antigen LFA.

MiraVista Diagnostics is leading the industry with a new Histoplasma Urine Antigen LFA. The rapid, non-invasive test has a proven clinical sensitivity of 93.18% and 96.97% specificity relative to culture proven cases, can be operated in low complexity clinical settings and requires no additional equipment.

Press Releases

Published Research

Technical Information

Distributors

Press Releases

May 26th, 2020 - Review our May 26th, 2020 Press Release regarding this new announcement
- Spanish Translation
- Portuguese Translation

Publications

Background

Histoplasmosis is a systemic infection caused by the dimorphic fungus Histoplasma capsulatum. Rapid diagnosis is important for early initiation of treatment in progressive disseminated and acute pulmonary histoplasmosis cases. Antigen detection has been proven useful for rapid diagnosis.

Development

We have developed an easy-to-use immunochromatographic lateral flow assay (LFA) for the visual detection of Histoplasma galactomannan antigen in urine.

The MiraVista Histoplasma Urine Antigen LFA test can aid in the diagnosis of Histoplasma infection.

Performance

The MiraVista Histoplasma Urine Antigen LFA has a proven clinical sensitivity of 93.18% and 96.97%

Download Product Information Sheet